期刊文献+

慢病毒介导的GHSR1a shRNA对结直肠癌细胞生长的影响 被引量:3

Lentivirus-mediated shRNA interference of ghrelin receptor blocks growth of colorectal cancer cells
下载PDF
导出
摘要 目的:构建生长激素促泌素受体1a(growth hormone secretagogue receptor 1a,GHSR1a)基因短发夹干扰RNA(short hairpin RNA,shRNA)慢病毒载体,感染人结直肠癌细胞系SW480,观察沉默GHSR1a基因对SW480细胞生长的影响,并探讨其作用机制。方法:构建特异性靶向GHSR1a基因的shRNA慢病毒表达载体和阴性对照序列慢病毒载体;建立稳定表达GHSR1a shRNA的SW480细胞、阴性对照细胞(NC)及空白对照细胞(BC),RTPCR检测GHSR1a的mRNA在细胞中的表达;通过Western blot技术检测细胞中GHSR1a、ghrelin、PTEN、p-AKT及p53蛋白的水平;CCK-8法测定GHSR1a shRNA对SW480细胞活力的影响;建立裸鼠结直肠癌皮下移植瘤模型,实验结束后处死裸鼠并测量各组裸鼠肿瘤重量;免疫组织化学法检测肿瘤组织中Ki-67和PTEN的阳性表达。结果:在体外实验中,GHSR1a在人结直肠癌细胞株Caco-2及SW480中的表达明显高于人正常结肠上皮细胞株NCM460的表达;成功建立了稳定表达GHSR1a shRNA的SW480细胞;GHSR1a shRNA能明显抑制SW480细胞GHSR1a mRNA及蛋白的表达;沉默GHSR1a基因后SW480细胞活力明显减弱;与NC组相比较,GHSR1a shRNA组细胞中PTEN mRNA及蛋白水平上调,AKT磷酸化被抑制,p53的表达明显增加;在体内实验中,与NC组相比较,GHSR1a shRNA组裸鼠结直肠癌皮下移植瘤重量明显减轻,同时Ki-67表达下调,PTEN表达上调。结论:慢病毒介导的GHSR1a shRNA对体内、外人结肠癌细胞的生长有明显抑制作用,该作用可能通过上调PTEN及其下游PI3K/AKT通路实现。 AIM: To investigate the therapeutic effects of lentivirus-mediated shRNA targeting growth hormone secretagogue receptor 1a( GHSR1a) on colorectal cancer cell line SW480 both in vitro and in vivo. METHODS: Human GHSR1a sequence was used for the design of shRNA targeting GHSR1a,which was introduced to lentivirus,followed by transfection into SW480 cells. CCK-8 assay was performed to detect cell viability. The mRNA expression of GHSR1a and PTEN in colorectal cancer cells was detected by RT-PCR. The protein levels of GHSR1a,ghrelin,PTEN,p-AKT and p53 were determined by Western blot. Stable GHSR1a silencing in SW480 xenografts in nude mice was established. After the mice were sacrificed and weighted,immunohistochemistry was used to detect the positive expression of Ki-67 and PTEN in the tumors. RESULTS: GHSR1a was over-expressed in the malignant cells in comparison with the normal cells in vitro.The tumor specific lentivirus-mediated shRNA targeting GHSR1a gene and GHSR1a knockdown SW480 cells were successfully constructed. After transfection with GHSR1a shRNA,the expression of GHSR1a at mRNA and protein levels was markedly inhibited in the SW480 cells. Furthermore,GHSR1a silencing by specific shRNA showed increased PTEN,inhibition of AKT phosphorylation and promotion of p53 release in the SW480 cells. In vivo results demonstrated that down-regulation of GHSR1a in the SW480 cells significantly decreased the expression of Ki-67 and increased the expression of PTEN in the tumor tissues,leading to a marked reduction in tumor weight in comparison to blank control or negative control tumors. CONCLUSION: Down-regulation of GHSR1a by shRNA technique inhibits the growth of colorectal cancer cell line and xenograft tumor through activation of the PTEN/PI3 K/AKT signaling pathways.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2016年第7期1227-1234,共8页 Chinese Journal of Pathophysiology
基金 岳阳市2014年第三批科技资助项目
关键词 结直肠癌 GHRELIN 生长激素促泌素受体1a PTEN Colorectal cancer Ghrelin Growth hormone secretagogue receptor 1a PTEN
  • 相关文献

参考文献17

  • 1Mora M, Adam V, Palomera E, et al. Ghrelin gene variants influence on metabolic syndrome components in aged spanish population[J]. PLoS One, 2015, 10(9):e0136931.
  • 2Eren M, ?olak ?, I??ksoy S, et al. Effect of H. pylori infection on gastrin, ghrelin, motilin, and gastroesophageal reflux[J]. Turk J Gastroenterol, 2015, 26(5):367-372.
  • 3Kurashina T, Dezaki K, Yoshida M, et al. The β-cell GHSR and downstream cAMP/TRPM2 signaling account for insulinostatic and glycemic effects of ghrelin[J]. Sci Rep, 2015, 5:14041.
  • 4Whirledge SD, Garcia JM, Smith RG, et al. Ghrelin partially protects against cisplatin-induced male murine gonadal toxicity in a GHSR-1a-dependent manner[J]. Biol Reprod, 2015, 92(3):76.
  • 5Hiura Y, Takiguchi S, Yamamoto K, et al. Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients:a prospective, randomized, placebo-controlled phase 2 study[J]. Cancer, 2012, 118(19):4785-4794.
  • 6Tian C, Zhang L, Hu D, et al. Ghrelin induces gastric cancer cell proliferation, migration, and invasion through GHS-R/NF-κB signaling pathway[J]. Mol Cell Biochem, 2013, 382(1-2):163-172.
  • 7Northrup R, Kuroda K, Duus EM, et al. Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model[J]. Support Care Cancer, 2013, 21(9):2409-2415.
  • 8Waseem T, Javaid-Ur-Rehman, Ahmad F, et al. Role of ghrelin axis in colorectal cancer:a novel association[J]. Peptides, 2008, 29(8):1369-1376.
  • 9Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products[J]. Cancer Res, 2007, 67(8):3853-3861.
  • 10胡俊杰,周志祥,梁建伟,周海涛,王征,张兴茂,曾维根.左、右半结肠癌患者临床病理特点及预后差异分析[J].中华医学杂志,2015,95(28):2268-2271. 被引量:43

二级参考文献21

  • 1张继民,刘明姬,溝井賢幸,椎葉健一,佐佐木巌,松野正纪.单核-巨噬细胞表达的胸苷磷酸化酶增强去氧氟尿苷抗结肠癌细胞活性[J].中华医学杂志,2004,84(9):718-724. 被引量:14
  • 2Papagiorgis PC, Zizi AE, Tseleni S, et al. The pattern of epidermal growth factor receptor variation with disease progression and aggressiveness in colorectal cancer depends on tumor location [ J ]. Oneol Lett,2012,3 : 1129-1135.
  • 3Bae JM, Kim JH, Cho NY, et al. Prognostic implication of the CpGisland methylator phenotype in colorectal cancers depends on tumour location[ J]. Br J Cance ,2013,109( 13 ) : 1004-1012.
  • 4Lee GH, Malietzis G, Askari A, et al. Is right-sided colon cancer different to left-sided colorectal cancer? A systematic review [ J ]. Eur J Surg Oncol,2015,41(4) :300-308.
  • 5Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location [ J ]. Ann Intern Med, 1990,113(10) :779-788.
  • 6Weiss JM, Pfau PR, O'Connor ES, et al. Mortality by stage for right-versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results-Medicare data [ J ]. J Clin Oneol, 2011,29(46) :4401-4409.
  • 7Moritani K, Hasegawa H, Okabayashi K, et al. Difference in the recurrence rate between right- and left-sided colon cancer: a 17- year experience at a single institution[ J]. Surg Today, 2014,44(21) :1685-1691.
  • 8Nawa T, Kato J, Kawamoto H, et al. Differences between right- and left-sided colon cancer in patient characteristics [ J ]. Cancer Morphol Histol, 2008,23( 6 ) :418-423.
  • 9Benedix F, Kube R, Meyer F, etal. Comparison of 17 641 patients with right-and left-sided colon cancer: differences in epidemiology, perioperativecourse, histology, and survival [ J ]. Dis Colon Rectum,2010,53( 1 ) :57-64.
  • 10Bara J, Nardelli J, Gadenne C, et al. Differences in the expression of mucus-associated antigens between proximal and distal human colon adenocarcinomas [ J ]. Br J cancer, 1984,49(6) :495-501.

共引文献47

同被引文献19

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部